News

Stellus Capital Investment Corporation Announces Financial Results Call

Stellus Capital Investment Corporation Announces Financial Results Call

Stellus Capital Investment Corporation Announces Financial Results Call

Stellus Capital Investment Corporation (NYSE: SCM) is ready to share its financial results for the fourth quarter and the entire year, which culminated on December 31, 2024. This significant announcement is set to be made public on an upcoming Tuesday, followed by a conference call designed for stakeholders to gain deeper insights into the company’s financial performance.

Key Conference Call Information

The highly anticipated conference call will occur on a Wednesday morning at 10:00 AM Central Time. Leading this discussion will be Robert T. Ladd, the Chief Executive Officer, partnered with W. Todd Huskinson, who serves as the Chief Financial Officer among other responsibilities.

Dial-In Details

Participants who wish to join the conference call via phone can do so by dialing 888-506-0062 for domestic lines. It is important to utilize the designated passcode 643131 for access. For those unable to attend, a replay will be accessible starting approximately two hours post-conclusion of the call, continuing through the following weeks.

Live Webcast Access

For a modern twist, attendees can join the conference via a live webcast. To gain access, visit the Public Company (SCIC) segment of our official website under the Events tab. The webcast will also feature a replay option that remains active for about 90 days, ensuring that stakeholders can gain access to vital information at their convenience.

Understanding Stellus Capital

Stellus Capital Investment Corporation is not just any ordinary investment entity. It is classified as an externally-managed, closed-end, non-diversified investment management firm, operating under regulations set forth for business development companies, particularly the Investment Company Act of 1940. The primary goal is clear—maximize returns for stockholders through a combination of current income and capital growth.

Investment Approach

The company focuses primarily on investing in private middle-market enterprises that typically earn between $5.0 million to $50.0 million in EBITDA (earnings before interest, taxes, depreciation, and amortization) through various financial instruments. These include first lien, second lien, unitranche, and mezzanine debt financing, along with corresponding equity investments. Stellus Capital Management, LLC oversees these investment activities, ensuring adept management and growth potential for stakeholders.

Commitment to Stakeholders

Stellus Capital demonstrates a strong commitment to transparency and communication with its investors. This upcoming conference call and the detailed financial reports are part of their broader strategy to keep stakeholders informed about company performance and future directions.

Engaging with Shareholders

In an increasingly competitive market, Stellus Capital recognizes the importance of engaging with shareholders. Through various forms of communication, including this conference call, they aim to foster trust and provide updates on financial health and strategic plans.

Frequently Asked Questions

What is the purpose of the conference call?

The conference call aims to discuss Stellus Capital's fourth-quarter and annual financial results, providing insights to stockholders.

Who will lead the conference call?

The call will be led by Robert T. Ladd, the Chief Executive Officer, and W. Todd Huskinson, the Chief Financial Officer.

How can I join the conference call?

Participants can join the call by dialing the provided number or attending the live webcast accessible through the official website.

What is Stellus Capital's investment focus?

The company primarily invests in private middle-market companies through various types of debt and equity financing.

How does Stellus Capital ensure transparency with shareholders?

Stellus Capital prioritizes communication and transparency through regular updates, financial reports, and engaging stakeholders during conference calls.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 37

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 52

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 46

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 63

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 40

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 35

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 28

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading

Top 5 Most Recently Viewed Articles

Aurelia Cellular Vitality Launch: Beauty Supplements Shake Up U.S. Market

Updated Category News Views 171

Aurelia Cellular Vitality just hit the U. S. market on February 17, 2026, and this ain't just another beauty brand strutting in with flashy ads and pretty bottles. They’re packing some serious science behind their hair, skin, and nail supplements formulated with their proprietary Eternacell™ complex designed to hit cellular-level vitality hard—think anti-aging but...

Continue Reading
Upcoming Financial Results Announcement for EWCZ

Updated Category News Views 117

Exciting Developments Ahead for European Wax Center, Inc. European Wax Center, Inc. (NASDAQ: EWCZ), recognized as a prominent franchisor specializing in out-of-home waxing services across the United States, is gearing up to unveil significant financial reports. Anticipation builds as the company prepares to disclose its fourth-quarter and fiscal year 2024 financial...

Continue Reading
Revolutionizing Nutritional Understanding Through Innovative Science

Updated Category News Views 138

A Comprehensive Look at Nutrient Intake Measurement A recent innovative framework designed to measure nutrient absorption offers a new perspective on how we understand the nutrients our bodies utilize. Traditional methods often focus solely on the total nutrient content, neglecting a crucial factor in nutrient intake: how much of those nutrients are actually absorbed by...

Continue Reading
Jennifer Cable Joins J2 Ventures Advisory Board to Drive Innovation

Updated Category News Views 168

Back in the day, Jennifer Cable took the reins as President of Thorlabs, positioning herself at the forefront of optical technology. Fast forward to her latest move—she joined J2 Ventures' advisory board, which sent ripples through the deep tech landscape. Traders were buzzing; they knew this wasn’t just another face in the crowd. With over $250 million under...

Continue Reading
Unlocking Monthly Income with Bank of America Dividends

Updated Category News Views 101

Understanding Bank of America Stock Dividends Bank of America Corporation (NASDAQ: BAC) is set to announce its earnings for the second quarter soon, generating buzz among investors regarding its dividend potential. Its current annual dividend yield stands at 2.20%, which translates to a quarterly dividend of 26 cents per share or $1.04 annually. Calculating Monthly Income...

Continue Reading